LLC;Charles Bisgaier;Michigan Life Therapeutics;Michigan Life Therapeutics, LLC
发明人:
Bisgaier, Charles L.
申请号：
AU2013207423
公开号：
AU2013207423A1
申请日:
2013.01.04
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
Methods of lowering the plasma LDL-C levels in a patient on a stable dose of statin where the patient has an LDL-C level above treatment goal. Methods of decreasing a patient's risk for developing coronary heart disease or having a recurrent cardiovascular event wherein the patient is on a stable dose of statin and the patient has an LDL-C level above treatment goal.
